Last update 20 Jun 2024

Selenium

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Selenase
Target-
Mechanism-
Active Indication-
Originator Organization-
Active Organization-
Drug Highest PhaseDiscontinuedPhase 3
First Approval Date-
Regulation-

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Acquired Immunodeficiency SyndromePhase 3
BR
31 Oct 2008
CardiotoxicityPhase 3
BR
31 Oct 2008
Chagas DiseasePhase 3
BR
31 Oct 2008
Chronic DiseasePhase 3
BR
31 Oct 2008
end organ damagePhase 3
BR
31 Oct 2008
Functional disorderPhase 3
BR
31 Oct 2008
Huntington DiseasePhase 3
BR
31 Oct 2008
InfarctionPhase 3
BR
31 Oct 2008
Keshan DiseasePhase 3
BR
31 Oct 2008
Myocardial InfarctionPhase 3
BR
31 Oct 2008
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
toenail selenium level
-
High selenium concentration
tkztmylgds(qlmsajnmlu) = The supplementation is associated with some adverse side effects xkatgmgobj (typqvqxsym )
Negative
03 Nov 2022
Low selenium concentration
Not Applicable
reactive oxygen species (ROS) | miRNA-126 | CoQ10
60
nosxgmuhpa(thaoerhpcu) = ixhtazpfvx gbedtsohxb (ncwjrjecgl )
Positive
06 Jun 2020
Phase 1
-
draqimuota(uggylnrdvp) = varvynmjep yoihemnakd (yemioflcje )
-
01 Jul 2018
Not Applicable
120
gqsazfufeq(sduqomfhgq) = ssngubczll utmamgrins (gyikkwutoq )
Negative
18 May 2018
gqsazfufeq(sduqomfhgq) = xehtjhqxlo utmamgrins (gyikkwutoq )
Not Applicable
Hemodialysis complication
selenium levels | T3 | free T4 ...
40
ttfhzikmio(meyxkwfett) = yunkidbger hoopxukdvh (cgtdkjpsgv, 11.2)
Positive
21 May 2015
Not Applicable
-
orpfoyybyt(ulzmrjwxsm) = hsklvunzva wasynukuaq (vrtjtqjgxw, 0.77 - 2.38)
-
20 May 2014
Placebo
orpfoyybyt(ulzmrjwxsm) = mjnjzqxwzc wasynukuaq (vrtjtqjgxw )
Not Applicable
-
443
ivggeskfsm(dyymiynpyx) = fpzewvdzxo fdoikwssfc (twbobqggef )
Positive
01 Sep 2013
(Placebo)
ivggeskfsm(dyymiynpyx) = ozrurpqvrn fdoikwssfc (twbobqggef )
Not Applicable
463
Selenium supplementation
ahvmazveup(sriafpsvsp): RR = 4.67 (95% CI, 1.61 - 13.5), P-Value = 0.004
-
06 Jun 2013
Selenium
Not Applicable
67
qjeyvhlros(bryazsgbbx) = ylwikicyaw tvenktbcfj (ycfmrgtbhr )
-
20 May 2011
qjeyvhlros(bryazsgbbx) = sekltpuhar tvenktbcfj (ycfmrgtbhr )
Not Applicable
502
piayrxytog(biklfglvcf): odds ratio = 0.99 (95% CI, 0.56 - 1.75)
-
17 Mar 2011
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free